| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000003853 |
| Receipt No. | R000004641 |
| Official scientific title of the study | Effects of High-absorptive Curcumin on Oxidative Stress Caused by Smoking |
| Date of disclosure of the study information | 2010/07/01 |
| Last modified on | 2017/07/06 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Effects of High-absorptive Curcumin on Oxidative Stress Caused by Smoking | |
| Title of the study (Brief title) | Effect of Curcumin on Oxidative Stress | |
| Region |
|
|
| Condition | ||
| Condition | Smoker | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of high-absorptive curcumin on oxidative stress caused by smoking |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Serum levels of oxidative stress markers |
| Key secondary outcomes | Serum levels of possible novel biomarkers of cardiovascular risk |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | High-absorptive Curcumin 30mg/day
po for 12 weeks |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Smokers who tried to but could not quit smoking after standard smoking cessation program at Smoking Cessation Clinic.
2. Smokers who will not quit smoking. |
|||
| Key exclusion criteria | 1) Unstable angina, recent (< 3 months)
myocardial infarction, severe coronary heart disease (left main trunk or 3 vessel disease), and recent (=< 3 months) orplanned (=< 6 months) AC bypass surgery / PCI 2) Severe arrhythmia (sustained ventricular tachycardia, ventricular fibrillation, and severe bradycardia with an indication of pacemaker implantation 3) Moderate or severe valvular diseases 4) Cardiomyopathy or progressive myocarditis 5) Severe respiratory diseases 6) Cardiogenic shock or systolic blood pressure < 80 mmHg 7) Renal failure (Cre >= 4.0 mg/dL or dialysis) 8) Severe liver dysfunction or liver cirrhosis 9) Recent (< 3 months) cerebrovascular disease 10) Malignancy 11) Poorly controlled diabetes (HbA1c >= 8.0%) 12) Anemia (Hb < 6.0 mg/dL) 13) Use of steroid 14) Past history of Curcumin allergy 15) Pregnancy, nursing, or a wish for pregnancy within 6 months 16) etc |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Koji Hasegawa |
| Organization | National Hospital Organization Kyoto
Medical Center |
| Division name | Division of Translational Research |
| Address | 1-1 Mukaihata-cho, Fukakusa, Fushimiku, Kyoto, Japan |
| TEL | 075-641-9161 |
| koj@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Koji Hasegawa |
| Organization | National Hospital Organization Kyoto |
| Division name | Division of Translational Research |
| Address | 1-1 Mukaihata-cho, Fukakusa, Fushimiku, Kyoto, Japan |
| TEL | 075-641-9161 |
| Homepage URL | |
| koj@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | National Hospital Organization Kyoto
Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Japan Health Sciences Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004641 |